Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||
Cash from operating activities | 68.53%1.43B | 1.52%849.74M | -17.51%837.05M | 246.74%1.01B | 292.64M |
Net profit before non-cash adjustment | 12.24%981.89M | 25.13%874.8M | 62.08%699.12M | 439.26%431.33M | --79.99M |
Total adjustment of non-cash items | 84.86%414.98M | 9.20%224.49M | -13.51%205.57M | -29.17%237.69M | --335.56M |
-Depreciation and amortization | 25.04%244.18M | 23.29%195.27M | -2.82%158.38M | -17.17%162.98M | --196.76M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | -46.27%33.44M | --62.24M |
-Disposal profit | -280.27%-6.26M | -363.10%-1.65M | -14.25%626K | -98.92%730K | --67.51M |
-Other non-cash items | 473.73%177.07M | -33.72%30.86M | 14.88%46.56M | 347.74%40.53M | --9.05M |
Changes in working capital | 114.12%35.23M | -268.94%-249.55M | -119.57%-67.64M | 381.21%345.64M | ---122.92M |
-Change in receivables | -66.81%-67.63M | -69.51%-40.55M | -845.79%-23.92M | 96.46%-2.53M | ---71.44M |
-Change in inventory | 82.29%-42.4M | -924.99%-239.4M | -59.57%29.02M | 188.55%71.77M | ---81.05M |
-Change in prepaid assets | 74.36%-1.3M | -1,167.50%-5.07M | ---400K | ---- | ---- |
-Change in payables | 69.15%107.03M | 269.74%63.28M | -126.29%-37.28M | 857.14%141.8M | --14.82M |
-Change in accrued expense | 274.40%54.76M | -363.04%-31.4M | -108.63%-6.78M | 1,415.47%78.55M | ---5.97M |
-Provision for loans, leases and other losses | -525.17%-15.23M | 112.67%3.58M | -160.84%-28.28M | 3,208.61%46.49M | --1.41M |
-Changes in other current liabilities | ---- | ---- | ---- | -50.49%9.57M | --19.33M |
Dividends paid (cash flow from operating activities) | |||||
Dividends received (cash flow from operating activities) | |||||
Interest paid (cash flow from operating activities) | 22.97%-2.03M | 49.21%-2.63M | 17.92%-5.18M | 21.29%-6.31M | -8.01M |
Interest received (cash flow from operating activities) | -3.41%1.47M | -3.18%1.52M | -3.97%1.57M | -9.15%1.64M | 1.8M |
Tax refund paid | 5.82%-284M | -24.23%-301.54M | -339.22%-242.73M | -2.44%-55.26M | -53.95M |
Other operating cash inflow (outflow) | -51.45%3.26M | -32.17%6.72M | -4.05%9.9M | 10.32M | 0 |
Operating cash flow | 107.80%1.15B | -7.79%553.81M | -37.76%600.62M | 315.12%965.06M | --232.48M |
Investing cash flow | |||||
Net PPE purchase and sale | -90.83%-199.73M | 8.05%-104.67M | -206.49%-113.83M | 75.71%-37.14M | ---152.9M |
Net intangibles purchase and sale | -4.25%-213M | -4.57%-204.31M | -128.86%-195.38M | 12.15%-85.37M | ---97.18M |
Net investment product transactions | --0 | --196K | --0 | 92.74%-4.51M | ---62.1M |
Repayment of advance payments to other parties and cash income from loans | -7.02%6.7M | 0.47%7.21M | -21.68%7.17M | -17.53%9.16M | --11.1M |
Net changes in other investments | -52.74%-17.63M | -347.75%-11.55M | 413.59%4.66M | 82.14%-1.49M | ---8.32M |
Investing cash flow | -35.30%-423.67M | -5.29%-313.12M | -149.16%-297.38M | 61.42%-119.35M | ---309.4M |
Financing cash flow | |||||
Net issuance payments of debt | 56.43%-135.06M | -874.74%-309.99M | 106.56%40.01M | -557.58%-609.99M | --133.31M |
Net common stock issuance | 613.99%6.84M | -99.91%958K | --1.02B | ---- | ---- |
Increase or decrease of lease financing | 35.37%-14.32M | -82.94%-22.16M | -51.73%-12.11M | -6.98%-7.98M | ---7.46M |
Cash dividends paid | -32.68%-165.24M | -21.58%-124.54M | -185.29%-102.43M | 3.41%-35.9M | ---37.17M |
Net other fund-raising expenses | 50.00%-1K | -100.00%-2K | ---1K | ---- | ---101K |
Financing cash flow | 32.47%-307.78M | -148.28%-455.73M | 244.36%943.91M | -838.23%-653.88M | --88.57M |
Net cash flow | |||||
Beginning cash position | -10.41%1.86B | 150.69%2.07B | 29.80%827.54M | 1.78%637.56M | --626.42M |
Current changes in cash | 295.02%419.37M | -117.24%-215.04M | 550.12%1.25B | 1,545.51%191.83M | --11.66M |
Effect of exchange rate changes | -29.42%-1.25M | -912.63%-962K | 94.88%-95K | -256.05%-1.86M | ---521K |
Cash adjustments other than cash changes | 0.00%-1K | ---1K | ---- | 0.00%-1K | ---1K |
End cash Position | 22.50%2.28B | -10.41%1.86B | 150.69%2.07B | 29.80%827.54M | --637.56M |
Free cash flow | 201.20%713.57M | -18.00%236.91M | -65.56%288.92M | 4,725.13%838.86M | ---18.14M |
Currency Unit | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |